Works matching IS 10837159 AND DT 2019 AND VI 24 AND IP 4
Results: 27
A Pairwise Meta‐Analysis of Induction Chemotherapy in Nasopharyngeal Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 505, doi. 10.1634/theoncologist.2018-0522
- By:
- Publication type:
- Article
Cutaneous Toxicity After Chemoradiotherapy and PD‐L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. e149, doi. 10.1634/theoncologist.2018-0674
- By:
- Publication type:
- Article
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 491, doi. 10.1634/theoncologist.2018-0787
- By:
- Publication type:
- Article
Endostatin and Oxaliplatin‐Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 461, doi. 10.1634/theoncologist.2019-0119
- By:
- Publication type:
- Article
Feasibility Assessment of Using the Complete Patient‐Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO‐CTCAE) Item Library.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. e146, doi. 10.1634/theoncologist.2018-0332
- By:
- Publication type:
- Article
Genomic Features for Therapeutic Insights of Chemotherapy‐Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. e142, doi. 10.1634/theoncologist.2018-0430
- By:
- Publication type:
- Article
Numbers Have Life: A Commentary on "Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit".
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 433, doi. 10.1634/theoncologist.2018-0834
- By:
- Publication type:
- Article
Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 549, doi. 10.1634/theoncologist.2018-0383
- By:
- Publication type:
- Article
Carcinoma of Unknown Primary with EML4‐ALK Fusion Response to ALK Inhibitors.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 449, doi. 10.1634/theoncologist.2018-0439
- By:
- Publication type:
- Article
A New Molecular Taxonomy to Predict Immune Checkpoint Inhibitor Sensitivity in Prostate Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 430, doi. 10.1634/theoncologist.2018-0819
- By:
- Publication type:
- Article
Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 425, doi. 10.1634/theoncologist.2018-0459
- By:
- Publication type:
- Article
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 537, doi. 10.1634/theoncologist.2018-0341
- By:
- Publication type:
- Article
Predictors of Survival in Patients with Advanced Gastrointestinal Malignancies Admitted to the Intensive Care Unit.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 483, doi. 10.1634/theoncologist.2018-0328
- By:
- Publication type:
- Article
An Open‐Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 457, doi. 10.1634/theoncologist.2018-0857
- By:
- Publication type:
- Article
Biomarkers for Programmed Death‐1 Inhibition in Prostate Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 444, doi. 10.1634/theoncologist.2018-0546
- By:
- Publication type:
- Article
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing Chemotherapy.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 563, doi. 10.1634/theoncologist.2018-0084
- By:
- Publication type:
- Article
Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 513, doi. 10.1634/theoncologist.2018-0305
- By:
- Publication type:
- Article
A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 459, doi. 10.1634/theoncologist.2018-0858
- By:
- Publication type:
- Article
Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 455, doi. 10.1634/theoncologist.2018-0740
- By:
- Publication type:
- Article
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 521, doi. 10.1634/theoncologist.2018-0290
- By:
- Publication type:
- Article
Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 475, doi. 10.1634/theoncologist.2018-0602
- By:
- Publication type:
- Article
EGFR Mutation Testing: Changing Patterns of Molecular Testing in Brazil.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. e137, doi. 10.1634/theoncologist.2018-0254
- By:
- Publication type:
- Article
Diagnosis and Management of Immune Checkpoint Inhibitor‐Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 435, doi. 10.1634/theoncologist.2018-0359
- By:
- Publication type:
- Article
Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 463, doi. 10.1634/theoncologist.2018-0217
- By:
- Publication type:
- Article
Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 498, doi. 10.1634/theoncologist.2017-0655
- By:
- Publication type:
- Article
"I need to know what makes somebody tick ...": Challenges and Strategies of Implementing Shared Decision‐Making in Individualized Oncology.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 555, doi. 10.1634/theoncologist.2017-0615
- By:
- Publication type:
- Article
The Association Between Common Clinical Characteristics and Postoperative Morbidity and Overall Survival in Patients with Glioblastoma.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 529, doi. 10.1634/theoncologist.2018-0056
- By:
- Publication type:
- Article